Bair Teresa Brophy
SEC CIK 1813058 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | CLO | 195.4K | — | $883.8K | 16 | 2022-11-17 | 2026-08-19 |
Most active insiders at KURA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WILSON TROY EDWARD | Pres, CEO, Dir | $2.35M | $327.3K |
| 2 | Leoni Mollie | Chief Medical Off | — | $1.19M |
| 3 | Bair Teresa Brophy | CLO | — | $690.8K |
| 4 | Powl Brian T. | Chief Commercial Off | — | $397.9K |
| 5 | Burrows Francis | CSO | — | $243.1K |
| 6 | FORD KATHLEEN | COO | — | $174.6K |
| 7 | DOYLE THOMAS JAMES | SVP, Fin, Accounting | — | $151.8K |
| 8 | Hasnain Faheem | Dir | — | $109.8K |
| 9 | Malley Thomas | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-21 16:30 | 2026-08-19 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $12.63 | -31.5K | 195.4K | -14% | -$397.7K |
| T | 2026-05-20 16:05 | 2026-05-18 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $9.38 | -2,256 | 226.9K | -1.0% | -$21.2K |
| M | 2026-01-27 | 2026-01-27 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $8.46 | -11.2K | 234.0K | -5% | -$94.8K |
| D | 2026-01-06 | 2026-01-02 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +50.0K | 238.1K | +27% | $0 |
| T | 2025-11-14 | 2025-11-14 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $11.18 | -8,804 | 188.1K | -4% | -$98.4K |
| T | 2025-11-14 | 2025-11-13 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +48.9K | 196.9K | +33% | $0 |
| T | 2025-09-29 | 2025-09-27 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +48.9K | 156.8K | +45% | $0 |
| T | 2025-09-29 | 2025-09-29 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $8.94 | -8,805 | 148.0K | -6% | -$78.7K |
| T | 2025-05-19 | 2025-05-19 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $5.96 | -1,559 | 107.9K | -1% | -$9,292 |
| M | 2025-01-28 | 2025-01-28 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $7.87 | -7,281 | 112.8K | -6% | -$57.3K |
| D | 2025-01-06 | 2025-01-02 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +46.2K | 115.2K | +67% | $0 |
| T | 2024-05-20 | 2024-05-20 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $22.15 | -2,615 | 69.0K | -4% | -$57.9K |
| 2024-01-31 | 2024-01-29 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $17.80 | -2,053 | 69.0K | -3% | -$36.5K | |
| D | 2024-01-04 | 2024-01-02 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +46.2K | 71.0K | +187% | $0 |
| D | 2023-02-21 | 2023-02-16 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | A - Grant | $0.00 | +23.1K | 23.1K | New | $0 |
| 2022-11-18 | 2022-11-17 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | CLO | S - Sale | $15.22 | -2,100 | 0 | -100% | -$32.0K |
Purchase Sale Sale after option exercise All abbreviations